Mark T S Williams (Mark Ts Williams)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Low Density Lipoprotein

Aortic Dissection

Multiple Myeloma

Top Venues

British journal of pharmacology

Therapeutic delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer Sun, Stefan Corradini, Feda Azab, Monica Shokeen, Barbara Muz, Katerina E Miari, Mina Maksimos, Camila Diedrich, Obed Asare, Kinan Alhallak, Chaelee Park, Berit Lubben, Yixuan Chen, Ola Adebayo, Hannah Bash, Sarah Kelley, Mark A Fiala, Diane E Bender, Haibin Zhou, Shaomeng Wang, Ravi Vij, Mark T S Williams, Abdel Kareem Azab
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma. Leukemia (2024)
Katerina E Miari, Mark T S Williams
Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance. British journal of pharmacology (2023)
Mark T S Williams, Monica L Guzman
Cancer microenvironment and pharmacological interventions. British journal of pharmacology 181 (2) (2023)
Mark T S Williams, Monica L Guzman
Cancer microenvironment and pharmacological interventions. British journal of pharmacology 181 (2) (2023)
Katerina E Miari, Mark T S Williams
Stromal Bone Marrow Fibroblasts and Mesenchymal Stem Cells Support Acute Myeloid Leukaemia Cells and Promote Therapy Resistance. British journal of pharmacology (2023)
Fahad Farhan, Mohammad Almarhoun, Aileen Wong, Amy S Findlay, Chris Bartholomew, Mark T S Williams, Toby W Hurd, Xinhua Shu
Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina. Cells 10 (11) (2021)
Neret Pujol-Navarro, Mohammed M Al Qaraghuli, Karina Kubiak-Ossowska, Manal M Alsaadi, Gillian A Horne, Richard L Soutar, Elpiniki Paspali, Valerie Anne Ferro, Mark T S Williams, Paul A Mulheran
Multiple myeloma: therapeutic delivery of antibodies and aptamers. Therapeutic delivery 12 (10) (2021)